Decentralised procedureThe decentralised procedure is a process for authorising medicines in more than one European Union member state at the same time.
DPThe decentralised procedure is a process for authorising medicines in more than one European Union member state at the same time.
DegradantsChemical products formed from the breakdown of a medicine due to for example light, temperature, water, reaction with non-active substances, or container and closure systems, etc.
Delivery deviceA device used for the delivery of a medicine or therapeutic agent via a specific route of administration (e.g. inhaler, dermal patch or infusion pump).
Delivery systemMedicine delivery systems encompass four main related aspects: Routes of delivery (ways in which the medications can be taken, such as orally, by injection, by inhalation, etc.). Delivery vehicles (dosage forms such as pills or slow-release granules). Chemical/biological properties of the(...)
DAHTAGerman Agency for Health Technology Assessment of the DIMDI. http://www.dimdi.de/static/de/hta/index.htm"
Development Safety Update ReportThe Development Safety Update Report is an annual review of safety information during clinical trials of a medicine under investigation – whether or not it is marketed. The main objectives of a Development Safety Update Report is to:
Summarise the current understanding and management of(...)
